Fresenius Kabi starts work on $250m US sterile drug plant
Fresenius Kabi has started work on a $250m (€220m) sterile drug manufacturing plant in Illinois, US.
Archives for September 24, 2017
Horizon launches new CRISPR screening services
Horizon Discovery has added new services to its functional genomic screening portfolio to enable customers to discover and validate novel targets.
BASF to increase 1,2-PDA capacity with new China plant
BASF has announced plans for a specialty amines plant at its site on the Nanjing Chemical Industry Park in China, citing increasing demand from customers in Asia.
Low budgets drive consolidation trend, say serialisation experts
According to industry delegates, smaller contract services firms struggling to meet track & trace implementation costs will look to consolidate with competitors in light of impending serialisation deadlines.
Anti-malaria drug casts light on cancer therapy
A treatment combining anti-malaria drug artemisinin and light-sensitive molecules could kill cancer cells and hinder tumour growth, say researchers.
Dutch CPO boosts bottling capacity
Contract packaging organisation (CPO) Tjoapack has invested in an additional bottling line at its facility in Ennen-Leur, the Netherlands.
Helomics, Indivumed partner on precision medicine platform
Pharma and diagnostic partners will gain access to a human cancer biospecimens and clinical data from patients to power clinical and translational research, says CRO.
EMA says it’s busy with Brexit and needs specifics of EU pre-submission probe
The EMA has asked the European Ombudsman for concrete details of its probe of pre-submission activities, warning that Brexit preparations have limited its capacity to respond.